Globus Medical, Inc.
GMED
$85.90
-$0.04-0.05%
NYSE
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 3.92% | -8.05% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 3.92% | -8.05% | |||
| Cost of Revenue | 3.15% | -8.07% | |||
| Gross Profit | 4.26% | -8.05% | |||
| SG&A Expenses | -3.68% | -2.30% | |||
| Depreciation & Amortization | 0.12% | 0.57% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.62% | -4.33% | |||
| Operating Income | 20.67% | -19.61% | |||
| Income Before Tax | 20.85% | -7.18% | |||
| Income Tax Expenses | 16.71% | 14.43% | |||
| Earnings from Continuing Operations | 21.94% | -11.59% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 21.94% | -11.59% | |||
| EBIT | 20.67% | -19.61% | |||
| EBITDA | 14.28% | -14.20% | |||
| EPS Basic | 22.21% | -12.21% | |||
| Normalized Basic EPS | 21.35% | -16.20% | |||
| EPS Diluted | 22.22% | -11.77% | |||
| Normalized Diluted EPS | 21.77% | -16.59% | |||
| Average Basic Shares Outstanding | -0.23% | 0.71% | |||
| Average Diluted Shares Outstanding | -0.58% | 1.18% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||